Indications and uses
To Use: Smooth on to cleansed face and throat daily before sun exposure.
Intervene Radiance Boosting Moisture SPF 15
- Manufacturer
- Elizabeth Arden, Inc
- Effective date
- 2011-01-13
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-05-31 22:29:07
Label at a glance#
ProductIntervene Radiance Boosting Moisture SPF 15
Active ingredientOCTINOXATE, AVOBENZONE, OXYBENZONE
Label structure10 sections
Label contents#
Full prescribing information#
DESCRIPTION
This multi-benefit moisturizer immediately boosts skin's appearance for a radiant, clearn, natural looking glow. With continued use, naturally-derived Biodormin technology supports skin's natural cell metabolism rate to help fight the visible aging effects caused by stress. Helps minimize the look of fine lines and combat the appearance of new ones. Provides deep hydration so skin stays younger looking longer. Clinically, dermatologist and allergy tested.
INDICATIONS AND USAGE
To Use: Smooth on to cleansed face and throat daily before sun exposure.
WARNINGS
Warning: For extrenal used only. Avoid contact with eyes. Discontinue use if signs of irritation or rash appear. If irritation or rash persists, consult a doctor. Keep out of reach of children.
OTC - ACTIVE INGREDIENT
Active Ingredients: Octinoxate 7.5% w/w, Avobenzone 3.0% w/w, Oxybenzone 3.0% w/w.
INACTIVE INGREDIENT
Other Ingredients: Water/Aqua/Eau, Ethylhexyl Methoxycinnamate, Glycerin, Butylene Glycol, Isononyl Isononanoate, Dimethicone, Cetearyl Glucoside, Benzophenone-3, Butyl Methoxydibenzoylmethane, Pentylene Glycol, Butyl Stearate, Tidecyl Salicylate, Cetyl Ricinoleate, Cyclopentasiloxane, Narcissus Tazetta Bulb Extract, Triolium Pratense (Clover) Flower Extract, Sodium Hyaluronate, Tocopherold, Tocopheryl Acetate, Caprylyl Glycol, Cetearyl Dimethicone Crosspolymer, Ethylhexyl Palmitate, Glyceryl Stearate, Sodium PCA, Trehalose, Urea, Hydrolyzed Soy Protein, Lecithin, Palmitoyl Tetrapeptide-7, Phospholipids, Polyphosphorylcholine Glycol Acrylate, Ammonium Acryloyldimethyltaurate/VP Copolymer, PEG-100 Stearate, PEG-8 Laurate, Steareth-20, PEG-60 Hydrogenated Castor Oil, Sodium Dodecylbenzenesulfonate, Polyquaternium-51, Styrene/Acrylates Copolymer, Hexylene Glycol, Isododecane, PEG-8, Zanthan Gum, Nylon-12, Disodium EDTA, Mica, Tin Oxide, Silica Dimethyl Silylate, Parfum/Fragrance, Butylphenyl Methylpropional, Citronellol, Limonene, Linalool, Benzoic Acid, Methylparaben, Phenoxyethanol, Postassium Sorbate, Propylparaben, Sorbic Acid, Chlorhexidine Digluconate, Chlorphenesin, Titanium Dioxide (CI 77891).
DOSAGE & ADMINISTRATION
Smooth on to face and throat.
OTC - KEEP OUT OF REACH OF CHILDREN
Keep out of reach of children.
OTC - PURPOSE
Provides SPF 15 sun protection.
OTC - WHEN USING
Avoid contact with eyes.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67938-1044-1 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c2ea-8e05-e053-dbdaa90a074a | BC1044 |
| 67938-1044-3 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c2ea-8e05-e053-dbdaa90a074a | BC1044 |
| 67938-1044-5 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c2ea-8e05-e053-dbdaa90a074a | BC1044 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67938-1044-1 | Intervene Radiance Boosting Moisture SPF 15 | 1 in 1 BOX | CREAM | 1 | 5 | |
| 67938-1044-2 | Intervene Radiance Boosting Moisture SPF 15 | 50 g in 1 JAR | CREAM | 50 | 5 | |
| 67938-1044-3 | Intervene Radiance Boosting Moisture SPF 15 | 1 in 1 BOX | CREAM | 1 | 5 | |
| 67938-1044-4 | Intervene Radiance Boosting Moisture SPF 15 | 15 g in 1 TUBE | CREAM | 15 | 5 | |
| 67938-1044-5 | Intervene Radiance Boosting Moisture SPF 15 | 1 in 1 BOX | CREAM | 1 | 5 | |
| 67938-1044-6 | Intervene Radiance Boosting Moisture SPF 15 | 7 g in 1 TUBE | CREAM | 7 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67938-1044 | INTERVENE RADIANCE BOOSTING MOISTURE SPF 15 (OCTINOXATE) CREAM [ELIZABETH ARDEN, INC] | 5 | Legacy NDC, 6 package rows | 20110805_ea2dee0e-d413-434d-89ec-ed9d5d51e278.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 5 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 5 | |
| OXYBENZONE | ACTIVE INGREDIENT | 95OOS7VE0Y | 5 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 5 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 5 | |
| OXYBENZONE | ACTIVE MOIETY | 95OOS7VE0Y | 5 | |
| ALPHA-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 5 | |
| BENZOIC ACID | INACTIVE INGREDIENT | 8SKN0B0MIM | 5 | |
| BUTYL STEARATE | INACTIVE INGREDIENT | 6Y0AI5605C | 5 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 5 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 5 | |
| CETEARYL GLUCOSIDE | INACTIVE INGREDIENT | 09FUA47KNA | 5 | |
| CHLORHEXIDINE GLUCONATE | INACTIVE INGREDIENT | MOR84MUD8E | 5 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 5 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 5 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 5 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 5 | |
| ETHYLHEXYL PALMITATE | INACTIVE INGREDIENT | 2865993309 | 5 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 5 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 5 | |
| HEXYLENE GLYCOL | INACTIVE INGREDIENT | KEH0A3F75J | 5 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 5 | |
| ISODODECANE | INACTIVE INGREDIENT | A8289P68Y2 | 5 | |
| ISONONYL ISONONANOATE | INACTIVE INGREDIENT | S4V5BS6GCX | 5 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 5 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 5 | |
| NARCISSUS TAZETTA BULB | INACTIVE INGREDIENT | K17762966S | 5 | |
| PALMITOYL TETRAPEPTIDE-7 | INACTIVE INGREDIENT | Q41S464P1R | 5 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 5 | |
| PEG-8 LAURATE | INACTIVE INGREDIENT | 762O8IWA10 | 5 | |
| PENTYLENE GLYCOL | INACTIVE INGREDIENT | 50C1307PZG | 5 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 5 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | 5 | |
| POLYOXYL 60 HYDROGENATED CASTOR OIL | INACTIVE INGREDIENT | 02NG325BQG | 5 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 5 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 5 | |
| SODIUM DODECYLBENZENESULFONATE | INACTIVE INGREDIENT | 554127163Y | 5 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 5 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | 5 | |
| STANNIC OXIDE | INACTIVE INGREDIENT | KM7N50LOS6 | 5 | |
| STEARETH-20 | INACTIVE INGREDIENT | L0Q8IK9E08 | 5 | |
| TREHALOSE | INACTIVE INGREDIENT | B8WCK70T7I | 5 | |
| TRIFOLIUM PRATENSE FLOWER | INACTIVE INGREDIENT | 4JS0838828 | 5 | |
| UREA | INACTIVE INGREDIENT | 8W8T17847W | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 5 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 5 |
Products#
Every source-derived product name is available through these pages.
- Intervene Radiance Boosting Moisture SPF 15
- Octinoxate
- AVOBENZONE
- OXYBENZONE
- WATER
- GLYCERIN
- BUTYLENE GLYCOL
- ISONONYL ISONONANOATE
- DIMETHICONE
- CETEARYL GLUCOSIDE
- PENTYLENE GLYCOL
- BUTYL STEARATE
- CYCLOMETHICONE 5
- ETHYLHEXYL PALMITATE
- ISODODECANE
- GLYCERYL MONOSTEARATE
- PEG-100 STEARATE
- PHENOXYETHANOL
- MICA
- POLYETHYLENE GLYCOL 400
- SODIUM PYRROLIDONE CARBOXYLATE
- UREA
- XANTHAN GUM
- BENZOIC ACID
- POLYOXYL 60 HYDROGENATED CASTOR OIL
- NARCISSUS TAZETTA BULB
- CHLORPHENESIN
- PEG-8 LAURATE
- EDETATE DISODIUM
- TREHALOSE
- STEARETH-20
- SORBIC ACID
- METHYLPARABEN
- CAPRYLYL GLYCOL
- SODIUM DODECYLBENZENESULFONATE
- TRIFOLIUM PRATENSE FLOWER
- HYALURONATE SODIUM
- STANNIC OXIDE
- ALPHA-TOCOPHEROL
- CHLORHEXIDINE GLUCONATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 67938-1044 | 67938-1044-2, 67938-1044-1, 67938-1044-4, 67938-1044-3, 67938-1044-6, 67938-1044-5 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INFILTRATION | 6 mg | ||
| UREA | UREA | 8W8T17847W | CREAM / VAGINAL | 0.64 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / OPHTHALMIC | 0.06 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | 388 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY, METERED / NASAL | 4 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SYRUP / ORAL | 740 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / SUBCUTANEOUS | 2 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | CREAM / TOPICAL | 10 %w/w | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | OINTMENT / TOPICAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUPPOSITORY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUSPENSION / ORAL | 15 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LIQUID / ORAL | 162 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, EXTENDED RELEASE / ORAL | 529 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | SYRUP / ORAL | 80 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAMUSCULAR | 6 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | FILM, SOLUBLE / ORAL | 29 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | CAPSULE, LIQUID FILLED / ORAL | 1122 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | FILM, SOLUBLE / BUCCAL | 3 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUPPOSITORY / RECTAL | 35 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, FILM COATED / ORAL | 4 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | PASTE, DENTIFRICE / DENTAL | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 1 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | LOTION / TOPICAL | 5 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | OINTMENT / TOPICAL | 29 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, EXTENDED RELEASE / ORAL | 0.17 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / PARENTERAL | 2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | EMULSION / TOPICAL | 0.2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | SOLUTION / ORAL | 80 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / RECTAL | 271 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUPPOSITORY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET, COATED / ORAL | 0.8 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | FILM, SOLUBLE / BUCCAL | 0.07 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | SOLUTION / TOPICAL | 0.3 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / NASAL | 100 mg/100ml | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / OPHTHALMIC | 2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER, FOR SUSPENSION / ORAL | 8 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7ea82ff0-45b3-4b0e-9d08-c10873534efa | ea2dee0e-d413-434d-89ec-ed9d5d51e278 | 2011-01-13 | Warnings | 7ea82ff0-45b3-4b0e-9d08-c10873534efa ea2dee0e-d413-434d-89ec-ed9d5d51e278 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.